Kathryn J Swoboda Selected Research

Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease)

1/2022	Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients.
1/2018	Clinical trial of L-Carnitine and valproic acid in spinal muscular atrophy type I.
12/2015	Responses to Fasting and Glucose Loading in a Cohort of Well Children with Spinal Muscular Atrophy Type II.
3/2014	Vitamin D intake is inadequate in spinal muscular atrophy type I cohort: correlations with bone health.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathryn J Swoboda Research Topics

Disease

44	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022 - 05/2005
4	Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease) 01/2022 - 03/2014
3	Alternating hemiplegia of childhood 01/2020 - 01/2015
2	Muscular Atrophy (Muscle Atrophy) 01/2021 - 11/2019
2	Neuromuscular Diseases (Neuromuscular Disease) 01/2021 - 01/2013
2	Neoplasms (Cancer) 01/2021 - 01/2020
2	Motor Neuron Disease (Primary Lateral Sclerosis) 12/2020 - 08/2012
2	Disease Progression 01/2020 - 12/2017
2	Rare Diseases (Rare Disease) 01/2018 - 12/2017
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 04/2015 - 03/2011
2	Muscular Diseases (Myopathy) 11/2013 - 02/2009
2	Weight Gain 08/2010 - 01/2009
2	Seizures (Absence Seizure) 06/2008 - 03/2002
1	Abnormal Reflex (Hyperreflexia) 12/2020
1	Muscle Weakness 12/2020
1	Atrophy 12/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Cachexia 01/2020
1	Nephrocalcinosis 10/2019
1	Fibrosis (Cirrhosis) 10/2019
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 10/2019
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2019
1	Neurodevelopmental Disorders 11/2018
1	Spastic Paraparesis 01/2018
1	Dystonia (Limb Dystonia) 01/2018
1	Pelizaeus-Merzbacher Disease 01/2018
1	Hereditary Spastic Paraplegia 01/2018
1	Premature Obstetric Labor (Premature Labor) 11/2017
1	Ataxia (Dyssynergia) 08/2017
1	Cerebellar Ataxia (Dysmetria) 08/2017
1	Brain Diseases (Brain Disorder) 08/2017
1	Glycogen Storage Disease Type II (Pompe's Disease) 07/2017
1	Arthrogryposis 09/2016
1	Hypoglycemia (Reactive Hypoglycemia) 12/2015
1	Insulin Resistance 12/2015
1	Agenesis of Cerebellar Vermis 05/2015
1	Bethlem myopathy 11/2013
1	Scleroatonic muscular dystrophy 11/2013
1	Muscular Dystrophies (Muscular Dystrophy) 04/2013
1	Epilepsy (Aura) 11/2012
1	Dystonia 12 09/2012
1	Hyperlipidemias (Hyperlipidemia) 08/2012
1	Acidosis 08/2012
1	Hyperglycemia 08/2012
1	Cough 05/2012

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2007
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2011
7	nusinersenIBA 01/2022 - 01/2016
7	Valproic Acid (Depakote)FDA LinkGeneric 01/2018 - 01/2009
5	Adenosine Triphosphatases (ATPase)IBA 01/2020 - 09/2012
5	Pharmaceutical PreparationsIBA 01/2019 - 08/2010
4	Carnitine (L-Carnitine)FDA LinkGeneric 01/2018 - 01/2009
3	ZolgensmaIBA 01/2022 - 06/2021
3	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 08/2012
2	RNA Precursors (Precursor, mRNA)IBA 01/2021 - 04/2015
2	Blood Proteins (Serum Proteins)IBA 01/2020 - 01/2013
2	CreatinineIBA 01/2020 - 10/2019
2	CalciumIBA 10/2019 - 03/2014
2	Antisense OligonucleotidesIBA 03/2016 - 01/2016
2	DystrophinIBA 04/2015 - 03/2011
2	Carrier Proteins (Binding Protein)IBA 04/2013 - 03/2011
1	MicroRNAs (MicroRNA)IBA 01/2022
1	RisdiplamIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	ProteomeIBA 01/2021
1	Conditioned Culture MediaIBA 01/2020
1	Actins (F Actin)IBA 01/2020
1	COP9 Signalosome ComplexIBA 01/2020
1	CalbindinsIBA 10/2019
1	Cystatin CIBA 10/2019
1	Calcium-Sensing ReceptorsIBA 10/2019
1	Insulin-Like Growth Factor Binding ProteinsIBA 10/2019
1	SodiumIBA 10/2019
1	Prion ProteinsIBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	PterinsIBA 01/2018
1	human GAA protein (Myozyme)FDA Link 07/2017
1	NeurocalcinIBA 01/2017
1	Ion Channels (Ion Channel)IBA 09/2016
1	Messenger RNA (mRNA)IBA 03/2016
1	Blood Glucose (Blood Sugar)IBA 12/2015
1	Insulin (Novolin)FDA Link 12/2015
1	Small Interfering RNA (siRNA)IBA 05/2015
1	Vitamin D FDA LinkGeneric 03/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2013
1	CollagenIBA 11/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2012
1	Oxygen (Dioxygen)IBA 05/2012
1	ConnexinsIBA 04/2011

Therapy/Procedure

18	Therapeutics 01/2022 - 11/2002
4	Denervation 12/2020 - 05/2005
1	Mechanical Ventilators (Ventilator) 01/2022
1	Drug Therapy (Chemotherapy) 01/2020
1	Cesarean Section (Caesarean Section) 11/2017
1	Enzyme Replacement Therapy 07/2017
1	Spinal Injections 01/2016
1	Resistance Training 10/2015
1	Noninvasive Ventilation 05/2012